The granting of the patent for HCW9218 methods of use claims directly impacts HCW Biologics as it could lead to new cancer treatment options. This development is highly relevant and important for the company's growth and innovation in the biotechnology sector. The positive impact on the stock price is likely due to the potential for increased revenue and market share in the cancer treatment market.